First Light Asset Management LLC lowered its position in shares of Amedisys Inc (NASDAQ:AMED) by 0.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,535 shares of the health services provider’s stock after selling 14 shares during the quarter. Amedisys makes up about 1.9% of First Light Asset Management LLC’s holdings, making the stock its 19th largest holding. First Light Asset Management LLC owned 0.27% of Amedisys worth $5,812,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in AMED. Russell Investments Group Ltd. raised its holdings in shares of Amedisys by 77.7% during the first quarter. Russell Investments Group Ltd. now owns 36,295 shares of the health services provider’s stock valued at $1,854,000 after acquiring an additional 15,875 shares during the last quarter. Great West Life Assurance Co. Can raised its holdings in shares of Amedisys by 8.0% during the first quarter. Great West Life Assurance Co. Can now owns 40,062 shares of the health services provider’s stock valued at $2,045,000 after acquiring an additional 2,960 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Amedisys by 125.0% during the first quarter. Bank of New York Mellon Corp now owns 781,256 shares of the health services provider’s stock valued at $39,915,000 after acquiring an additional 433,956 shares during the last quarter. Suntrust Banks Inc. raised its holdings in shares of Amedisys by 2.0% during the first quarter. Suntrust Banks Inc. now owns 5,465 shares of the health services provider’s stock valued at $279,000 after acquiring an additional 107 shares during the last quarter. Finally, Comerica Bank raised its holdings in shares of Amedisys by 4.2% during the first quarter. Comerica Bank now owns 30,909 shares of the health services provider’s stock valued at $1,670,000 after acquiring an additional 1,258 shares during the last quarter. 96.55% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Amedisys Inc (AMED) Shares Sold by First Light Asset Management LLC” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/amedisys-inc-amed-shares-sold-by-first-light-asset-management-llc/1599090.html.

In other news, insider David B. Pearce sold 1,000 shares of the company’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $50.00, for a total transaction of $50,000.00. Following the completion of the sale, the insider now directly owns 10,488 shares in the company, valued at approximately $524,400. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Bruce D. Perkins acquired 2,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were purchased at an average price of $46.60 per share, with a total value of $93,200.00. Following the completion of the acquisition, the director now owns 15,825 shares in the company, valued at $737,445. The disclosure for this purchase can be found here. Insiders own 2.80% of the company’s stock.

Amedisys Inc (NASDAQ AMED) traded up 0.68% on Friday, hitting $55.96. The stock had a trading volume of 243,241 shares. The company’s 50-day moving average price is $50.25 and its 200 day moving average price is $54.94. Amedisys Inc has a one year low of $34.58 and a one year high of $65.91. The firm has a market cap of $1.89 billion, a price-to-earnings ratio of 47.83 and a beta of 0.84.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, July 26th. The health services provider reported $0.62 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.12. The company had revenue of $378.80 million during the quarter, compared to the consensus estimate of $380.80 million. Amedisys had a return on equity of 13.71% and a net margin of 2.70%. Amedisys’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.42 EPS. Analysts expect that Amedisys Inc will post $2.21 earnings per share for the current year.

A number of brokerages have commented on AMED. Royal Bank Of Canada reissued a “hold” rating and set a $56.00 target price on shares of Amedisys in a report on Monday, June 5th. Mizuho cut Amedisys from a “buy” rating to a “neutral” rating and set a $50.00 price target for the company. in a report on Wednesday, July 26th. BidaskClub cut Amedisys from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $60.00 price target on shares of Amedisys in a report on Friday, September 15th. Finally, Bank of America Corporation started coverage on Amedisys in a report on Monday, August 21st. They issued a “neutral” rating and a $55.00 price target for the company. Seven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $56.44.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.